| Authors: |
Gatz SA; Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.; Department of Paediatric Oncology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom., Berlanga P; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Gustave Roussy, Inserm U1360, Villejuif, France., Le Teuff G; Biostatistics and Epidemiology Unit, Inserm U1018, CESP, Gustave Roussy, Université Paris-Saclay, UVSQ, Villejuif, France., Valiev I; Université Paris-Saclay, Gustave Roussy , Inserm U1361, Villejuif, France., Leruste A; Institut Curie , SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), PSL Research University, Paris, France., André N; Department of Pediatric Oncology, AP-HM, Hôpital de la Timone, Marseille, France.; Inserm UMR 1068, CNRS UMR 7258, Aix Marseille Université U105, Cancer Research Center (CRCM), Marseille, France., Bluteau D; Université Paris-Saclay, Gustave Roussy, Inserm U1360, Villejuif, France.; EPHE, Gustave Roussy, PSL University, Villejuif, France., Corradini N; Department of Pediatric Oncology, Institut d'Hematologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France., Rubino J; Clinical Research Direction, Gustave Roussy, Villejuif, France., Thomas F; Pharmacology Department, Inserm, CRCT, Institut Universitaire du Cancer Toulouse - Oncopole, University Toulouse, Toulouse, France., Nebchi S; Biostatistics and Epidemiology Unit, Inserm U1018, CESP, Gustave Roussy, Université Paris-Saclay, UVSQ, Villejuif, France., Karamouza E; Biostatistics and Epidemiology Unit, Inserm U1018, CESP, Gustave Roussy, Université Paris-Saclay, UVSQ, Villejuif, France., Petit J; Pharmacology Department, Inserm, CRCT, Institut Universitaire du Cancer Toulouse - Oncopole, University Toulouse, Toulouse, France., Thebaud E; Department of Pediatric Oncology, Centre Hospitalier Universitaire de Nantes, Nantes, France., Rubio-San-Simón A; Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Hospital Niño Jesús, Madrid, Spain., van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Marshall LV; Paediatric and Adolescent Oncology Drug Development Unit, Royal Marsden Hospital, The Institute of Cancer Research, London, United Kingdom., Raimbault S; Department of Pediatric Oncology, Centre Oscar Lambret, Lille, France., Canete A; University Hospital La Fe, Valencia, Spain., Ducassou S; Department of Pediatric Hemato-Oncology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Makin G; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.; Department of Paediatric Oncology, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom., Casanova M; Fondazione IRCCS Istituto Nazionale dei Tumori , Milan, Italy., De Carli E; Department of Pediatric Oncology, Centre Hospitalier Universitaire d'Angers, Angers, France., Petit A; Centre de Recherche Saint-Antoine, UMR_S938, AP-HP, Hôpital Armand Trousseau, Sorbonne Université, Paris, France., Cardon M; Université Paris-Saclay, Gustave Roussy, Inserm U1360, Villejuif, France.; Bioinformatic Platform, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Lacroix L; Department of Medical Biology and Pathology, Biobank and Genomic Platform, AMMICa, Inserm US23/CNRS UMS3655, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Pierron G; Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France., Schleiermacher G; Institut Curie , SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), PSL Research University, Paris, France.; Inserm U1330, Translational Research in Pediatric Oncology (RTOP), Research Center, Institut Curie, PSL Research University, Paris, France., Hubank MJF; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Soriano Fernandez A; Laboratory of Translational Research in Child and Adolescent Cancer, Vall d'Hebron Research Institute (VHIR), UAB, Barcelona, Spain., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Castel D; Université Paris-Saclay, Gustave Roussy, Inserm U1360, Villejuif, France., Adam-de Beaumais T; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France., Paoletti X; Biostatistics and Epidemiology Unit, Inserm U1018, CESP, Gustave Roussy, Université Paris-Saclay, UVSQ, Villejuif, France., Lukka PB; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca (United States), Gaithersburg, Maryland., Baldry R; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca (United Kingdom), Cambridge, United Kingdom., Mortimer PGS; Oncology R&D, AstraZeneca (United Kingdom), Cambridge, United Kingdom., Nikolaev SI; Université Paris-Saclay, Gustave Roussy , Inserm U1361, Villejuif, France., Geoerger B; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Gustave Roussy, Inserm U1360, Villejuif, France. |
